A sensitive capillary GC assay for the determination of sparteine oxidation products in microsomal fractions of human liver

This publication has 23 references indexed in Scilit:

• Oxidation of sparteines by cytochrome P-450: evidence against the formation of N-oxides
  Journal of Medicinal Chemistry, 1984
• Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism
  Biochemistry, 1984
• The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions.
  Journal of Medical Genetics, 1983
• Inhibition of sparteine oxidation in human liver by tricyclic antidepressants and other drugs
  Life Sciences, 1983
• Impaired oxidation of debrisoquine in patients with perhexiline neuropathy.
  BMJ, 1982
• In vitro metabolism of sparteine by human liver: competitive inhibition by debrisoquine
  Canadian Journal of Physiology and Pharmacology, 1982
• Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strains
  Journal of Pharmacy and Pharmacology, 1981
• PHENFORMIN-INDUCED LACTICACIDOSIS ASSOCIATED WITH IMPAIRED DEBRISOQUINE HYDROXYLATION
  The Lancet, 1981
• Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver.
  Published by Wiley ,1981
• Defective N-oxidation of sparteine in man: A new pharmacogenetic defect
  European Journal of Clinical Pharmacology, 1979